Xconomy: Alexion News, Articles and Opinions

“alexion” Archives

Entry	Author	Date	Location
Bio Roundup: Merger Drama, FDA Trauma, Big IPOs, CRISPR Fights & More	Alex Lash	06/28/19	National
Halozyme Gets $30M from Argenx in Licensing Deal Worth Up to $530M	Sarah de Crescenzo	02/06/19	San Diego
For San Antonio’s Consideration: A Biotech Incubator and Accelerator	David Holley	04/08/16	Texas
Cubist Maintains Growth Streak, As Investors Fear Generic Threat, Thin Pipeline	Ryan McBride	01/25/10	Boston
Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
Decentralized Clinical Trials: The Call for a New Paradigm
Virtual/hybrid trials and decentralized research can better integrate healthcare into patients’ lives and accelerate approval of new medications
PRA Health Sciences

Sponsored · Whitepaper
How Big Is the US Market for Medical Devices & Technologies?
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
IBM Watson

Sponsored · Whitepaper
Bridging the Diversity Gap with Decentralized Trials
How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender
PRA Health Sciences

Xconomy on Demand

We offer a number of ways to subscribe for free!